Intchains Group
ICG
SATO TECHNOLOGIES CORP
CCPUF
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
Bitfarms
BITF
US Stock MarketDetailed Quotes
EYPT EyePoint Pharmaceuticals
- 7.200
- -0.380-5.01%
Close Dec 27 16:00 ET
- 7.200
- 0.0000.00%
Post 16:00 ET
491.41MMarket Cap-3.62P/E (TTM)
7.740High7.190Low673.68KVolume7.570Open7.580Pre Close4.91MTurnover1.44%Turnover RatioLossP/E (Static)68.25MShares30.99052wk High2.25P/B337.08MFloat Cap6.90052wk Low--Dividend TTM46.82MShs Float72.200Historical High--Div YieldTTM7.26%Amplitude2.190Historical Low7.288Avg Price1Lot Size
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
EyePoint Pharmaceuticals Stock Forum
EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(5.2%),TCG Crossover Fund II, L.P.(5.2%), etc.
Positive
Positive interim DME trial data showing significant BCVA improvement of +8.9 letters
Successful completion of $161M equity financing
Extended cash runway into 2027
Initiation of Phase 3 LUGANO trial in wet AMD
Opening of new 40,000 sq ft cGMP manufacturing facility
Negative
Revenue declined 31% YoY to $10.5M from $15.2M
Net loss increased to $29.4M from $12.6M YoY
Operating expenses increased to $43.3M from $29.6M YoY
Cash position decreased to...
EyePoint Pharmaceuticals Inc - Commences $100 Million Public Offering
📊⚡️📊
Benzinga· 2 mins ago
EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.8%)
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
No comment yet